Read about the latest breakthroughs, awards and ongoing work from the SGC. Discover how our work is making a global impact and driving forward the field of drug discovery. Interested in getting first the latest news from SGC?
Researchers at the Structural Genomics Consortium (SGC), spanning its UNC Chapel Hill and Toronto sites, have been awarded funding through the inaugural 2025 End AxD Grant Program to develop the first small molecules targeting the GFAP protein in Alexander disease (AxD).
The project is led…
The American Association for Cancer Research has recognized Cheryl H. Arrowsmith, Chief Scientist of the Structural Genomics Consortium (SGC), Senior Scientist at the Princess Margaret Cancer Centre, University Health Network, and Professor in the Department of Medical Biophysics at the…
Toronto, Canada — April 13 — The Structural Genomics Consortium (SGC) today announced that it will expand its leadership team to help accelerate the next phase of Target 2035, a global effort to develop a pharmacological modulator…
Categories